Global Supplement CDMO Supply, Demand and Key Producers, 2026-2032
The global Supplement CDMO market size is expected to reach $ 59586 million by 2032, rising at a market growth of 6.3% CAGR during the forecast period (2026-2032).
Supplement CDMO refers to a professional organization that provides one-stop outsourcing services such as R&D, formula optimization, clinical trial support, large-scale production and packaging for health products (such as dietary supplements, functional foods, nutritional preparations, etc.). This model helps brands reduce R&D investment, accelerate product launch, and meet compliance requirements in the global market.
The outlook for the dietary supplement CDMO industry is generally positive, driven by sustained global demand for dietary supplements, functional foods, sports nutrition, healthy aging solutions, and personalized nutrition. To reduce capital investment in in-house production lines and shorten time-to-market for new products—while also navigating complex requirements such as formulation development, raw material screening, stability testing, regulatory compliance, and multi-dosage form manufacturing—brand owners are increasingly outsourcing R&D, pilot production, large-scale manufacturing, and packaging services to specialized CDMOs. Future industry growth will be increasingly concentrated in high-value-added segments—including softgels, hard capsules, tablets, powders, gummies, liquids, and complex dosage forms—alongside continued market expansion for products based on plant extracts, probiotics, proteins, vitamins and minerals, and functional active ingredients. As markets in the US, Europe, and Asia raise standards for quality traceability, GMP certification, clean-label attributes, and supply chain transparency, large-scale CDMOs possessing robust R&D capabilities, regulatory support, mass production capacity, and global supply chain networks are poised to capture greater market share; the industry is also trending toward increased specialization, economies of scale, and accelerated M&A activity.
This report is a detailed and comprehensive analysis of the world market for Supplement CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Supplement CDMO that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Supplement CDMO market
2. What is the demand of the global Supplement CDMO market?
3. What is the year over year growth of the global Supplement CDMO market?
4. What is the total value of the global Supplement CDMO market?
5. Who are the Major Players in the global Supplement CDMO market?
6. What are the growth factors driving the market demand?
Supplement CDMO refers to a professional organization that provides one-stop outsourcing services such as R&D, formula optimization, clinical trial support, large-scale production and packaging for health products (such as dietary supplements, functional foods, nutritional preparations, etc.). This model helps brands reduce R&D investment, accelerate product launch, and meet compliance requirements in the global market.
The outlook for the dietary supplement CDMO industry is generally positive, driven by sustained global demand for dietary supplements, functional foods, sports nutrition, healthy aging solutions, and personalized nutrition. To reduce capital investment in in-house production lines and shorten time-to-market for new products—while also navigating complex requirements such as formulation development, raw material screening, stability testing, regulatory compliance, and multi-dosage form manufacturing—brand owners are increasingly outsourcing R&D, pilot production, large-scale manufacturing, and packaging services to specialized CDMOs. Future industry growth will be increasingly concentrated in high-value-added segments—including softgels, hard capsules, tablets, powders, gummies, liquids, and complex dosage forms—alongside continued market expansion for products based on plant extracts, probiotics, proteins, vitamins and minerals, and functional active ingredients. As markets in the US, Europe, and Asia raise standards for quality traceability, GMP certification, clean-label attributes, and supply chain transparency, large-scale CDMOs possessing robust R&D capabilities, regulatory support, mass production capacity, and global supply chain networks are poised to capture greater market share; the industry is also trending toward increased specialization, economies of scale, and accelerated M&A activity.
Report Scope
This report studies the global Supplement CDMO demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for Supplement CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Supplement CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Supplement CDMO total market, 2021-2032, (USD Million)
- Global Supplement CDMO total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: Supplement CDMO total market, key domestic companies, and share, (USD Million)
- Global Supplement CDMO revenue by player, revenue and market share 2021-2026, (USD Million)
- Global Supplement CDMO total market by Type, CAGR, 2021-2032, (USD Million)
- Global Supplement CDMO total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Supplement CDMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Supplement CDMO Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Supplement CDMO Market, Segmentation by Type:
- ?Small Molecule CDMO?
- ?Large Molecule CDMO?
Global Supplement CDMO Market, Segmentation by Product Dosage Forms:
- Capsule Supplement CDMO
- Tablet Supplement CDMO
- Powder Supplement CDMO
- Liquid Supplement CDMO
- Others
Global Supplement CDMO Market, Segmentation by Production Models:
- Custom Formulation
- Ready-made Formulation
- Custom + Ready-made Formulation
Global Supplement CDMO Market, Segmentation by Application:
- Sports Nutrition (Protein Powder, Amino Acids, Creatine, Electrolytes, etc.)
- Digestive Health (Probiotics, Prebiotics, Digestive Enzymes, Dietary Fiber, etc.)
- Immune Health (Vitamin C, Zinc, Elderberry, Immune Support Blends, etc.)
- Bone & Joint Health (Calcium, Glucosamine, Chondroitin, Collagen, etc.)
- Cardiovascular Health (Fish Oil, Omega-3, CoQ10, Plant Sterols, etc.)
- Beauty & Wellness (Collagen, Biotin, Beauty Gummies, etc.)
- Sleep & Mood Health (Melatonin, Magnesium, Theanine, etc.)
- Others
Companies Profiled:
- Biofarma Group
- SFI Health Solutions
- TCI Bio
- Lonza
- HERMES PHARMA
- Vitaquest
- Catalent
- KD Pharma Group
- Pharma Tech Industries
- Pierre Fabre
- NutraPak USA
- American Health Formulations
- Aenova Group
- Robinson Pharma
- CAPTEK Softgel International
- Makers Nutrition
- Goerlich Pharma
- API Co., Ltd
- Kolmar BNH
- COSMAX BIO
- NOVAREX
- ORi Bionature
- Sirio Pharma
- Baihe Biotech
Key Questions Answered
1. How big is the global Supplement CDMO market?2. What is the demand of the global Supplement CDMO market?
3. What is the year over year growth of the global Supplement CDMO market?
4. What is the total value of the global Supplement CDMO market?
5. Who are the Major Players in the global Supplement CDMO market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Supplement CDMO Introduction
1.2 World Supplement CDMO Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Supplement CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Supplement CDMO Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Supplement CDMO Revenue (2021-2032)
1.3.3 China Based Company Supplement CDMO Revenue (2021-2032)
1.3.4 Europe Based Company Supplement CDMO Revenue (2021-2032)
1.3.5 Japan Based Company Supplement CDMO Revenue (2021-2032)
1.3.6 South Korea Based Company Supplement CDMO Revenue (2021-2032)
1.3.7 ASEAN Based Company Supplement CDMO Revenue (2021-2032)
1.3.8 India Based Company Supplement CDMO Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Supplement CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Supplement CDMO Consumption Value (2021-2032)
2.2 World Supplement CDMO Consumption Value by Region
2.2.1 World Supplement CDMO Consumption Value by Region (2021-2026)
2.2.2 World Supplement CDMO Consumption Value Forecast by Region (2027-2032)
2.3 United States Supplement CDMO Consumption Value (2021-2032)
2.4 China Supplement CDMO Consumption Value (2021-2032)
2.5 Europe Supplement CDMO Consumption Value (2021-2032)
2.6 Japan Supplement CDMO Consumption Value (2021-2032)
2.7 South Korea Supplement CDMO Consumption Value (2021-2032)
2.8 ASEAN Supplement CDMO Consumption Value (2021-2032)
2.9 India Supplement CDMO Consumption Value (2021-2032)
3 WORLD SUPPLEMENT CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Supplement CDMO Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Supplement CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Supplement CDMO in 2025
3.2.3 Global Concentration Ratios (CR8) for Supplement CDMO in 2025
3.3 Supplement CDMO Company Evaluation Quadrant
3.4 Supplement CDMO Market: Overall Company Footprint Analysis
3.4.1 Supplement CDMO Market: Region Footprint
3.4.2 Supplement CDMO Market: Company Product Type Footprint
3.4.3 Supplement CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Supplement CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Supplement CDMO Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Supplement CDMO Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Supplement CDMO Consumption Value Comparison
4.2.1 United States VS China: Supplement CDMO Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Supplement CDMO Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Supplement CDMO Companies and Market Share, 2021-2026
4.3.1 United States Based Supplement CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Supplement CDMO Revenue, (2021-2026)
4.4 China Based Companies Supplement CDMO Revenue and Market Share, 2021-2026
4.4.1 China Based Supplement CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Supplement CDMO Revenue, (2021-2026)
4.5 Rest of World Based Supplement CDMO Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Supplement CDMO Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Supplement CDMO Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Supplement CDMO Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 ?Small Molecule CDMO?
5.2.2 ?Large Molecule CDMO?
5.3 Market Segment by Type
5.3.1 World Supplement CDMO Market Size by Type (2021-2026)
5.3.2 World Supplement CDMO Market Size by Type (2027-2032)
5.3.3 World Supplement CDMO Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PRODUCT DOSAGE FORMS
6.1 World Supplement CDMO Market Size Overview by Product Dosage Forms: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Product Dosage Forms
6.2.1 Capsule Supplement CDMO
6.2.2 Tablet Supplement CDMO
6.2.3 Powder Supplement CDMO
6.2.4 Liquid Supplement CDMO
6.2.5 Others
6.3 Market Segment by Product Dosage Forms
6.3.1 World Supplement CDMO Market Size by Product Dosage Forms (2021-2026)
6.3.2 World Supplement CDMO Market Size by Product Dosage Forms (2027-2032)
6.3.3 World Supplement CDMO Market Size Market Share by Product Dosage Forms (2027-2032)
7 MARKET ANALYSIS BY PRODUCTION MODELS
7.1 World Supplement CDMO Market Size Overview by Production Models: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Models
7.2.1 Custom Formulation
7.2.2 Ready-made Formulation
7.2.3 Custom + Ready-made Formulation
7.3 Market Segment by Production Models
7.3.1 World Supplement CDMO Market Size by Production Models (2021-2026)
7.3.2 World Supplement CDMO Market Size by Production Models (2027-2032)
7.3.3 World Supplement CDMO Market Size Market Share by Production Models (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Supplement CDMO Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Sports Nutrition (Protein Powder, Amino Acids, Creatine, Electrolytes, etc.)
8.2.2 Digestive Health (Probiotics, Prebiotics, Digestive Enzymes, Dietary Fiber, etc.)
8.2.3 Immune Health (Vitamin C, Zinc, Elderberry, Immune Support Blends, etc.)
8.2.4 Bone & Joint Health (Calcium, Glucosamine, Chondroitin, Collagen, etc.)
8.2.5 Cardiovascular Health (Fish Oil, Omega-3, CoQ10, Plant Sterols, etc.)
8.2.6 Beauty & Wellness (Collagen, Biotin, Beauty Gummies, etc.)
8.2.7 Sleep & Mood Health (Melatonin, Magnesium, Theanine, etc.)
8.2.8 Others
8.3 Market Segment by Application
8.3.1 World Supplement CDMO Market Size by Application (2021-2026)
8.3.2 World Supplement CDMO Market Size by Application (2027-2032)
8.3.3 World Supplement CDMO Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Biofarma Group
9.1.1 Biofarma Group Details
9.1.2 Biofarma Group Major Business
9.1.3 Biofarma Group Supplement CDMO Product and Services
9.1.4 Biofarma Group Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Biofarma Group Recent Developments/Updates
9.1.6 Biofarma Group Competitive Strengths & Weaknesses
9.2 SFI Health Solutions
9.2.1 SFI Health Solutions Details
9.2.2 SFI Health Solutions Major Business
9.2.3 SFI Health Solutions Supplement CDMO Product and Services
9.2.4 SFI Health Solutions Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 SFI Health Solutions Recent Developments/Updates
9.2.6 SFI Health Solutions Competitive Strengths & Weaknesses
9.3 TCI Bio
9.3.1 TCI Bio Details
9.3.2 TCI Bio Major Business
9.3.3 TCI Bio Supplement CDMO Product and Services
9.3.4 TCI Bio Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 TCI Bio Recent Developments/Updates
9.3.6 TCI Bio Competitive Strengths & Weaknesses
9.4 Lonza
9.4.1 Lonza Details
9.4.2 Lonza Major Business
9.4.3 Lonza Supplement CDMO Product and Services
9.4.4 Lonza Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Lonza Recent Developments/Updates
9.4.6 Lonza Competitive Strengths & Weaknesses
9.5 HERMES PHARMA
9.5.1 HERMES PHARMA Details
9.5.2 HERMES PHARMA Major Business
9.5.3 HERMES PHARMA Supplement CDMO Product and Services
9.5.4 HERMES PHARMA Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 HERMES PHARMA Recent Developments/Updates
9.5.6 HERMES PHARMA Competitive Strengths & Weaknesses
9.6 Vitaquest
9.6.1 Vitaquest Details
9.6.2 Vitaquest Major Business
9.6.3 Vitaquest Supplement CDMO Product and Services
9.6.4 Vitaquest Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Vitaquest Recent Developments/Updates
9.6.6 Vitaquest Competitive Strengths & Weaknesses
9.7 Catalent
9.7.1 Catalent Details
9.7.2 Catalent Major Business
9.7.3 Catalent Supplement CDMO Product and Services
9.7.4 Catalent Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Catalent Recent Developments/Updates
9.7.6 Catalent Competitive Strengths & Weaknesses
9.8 KD Pharma Group
9.8.1 KD Pharma Group Details
9.8.2 KD Pharma Group Major Business
9.8.3 KD Pharma Group Supplement CDMO Product and Services
9.8.4 KD Pharma Group Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 KD Pharma Group Recent Developments/Updates
9.8.6 KD Pharma Group Competitive Strengths & Weaknesses
9.9 Pharma Tech Industries
9.9.1 Pharma Tech Industries Details
9.9.2 Pharma Tech Industries Major Business
9.9.3 Pharma Tech Industries Supplement CDMO Product and Services
9.9.4 Pharma Tech Industries Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Pharma Tech Industries Recent Developments/Updates
9.9.6 Pharma Tech Industries Competitive Strengths & Weaknesses
9.10 Pierre Fabre
9.10.1 Pierre Fabre Details
9.10.2 Pierre Fabre Major Business
9.10.3 Pierre Fabre Supplement CDMO Product and Services
9.10.4 Pierre Fabre Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Pierre Fabre Recent Developments/Updates
9.10.6 Pierre Fabre Competitive Strengths & Weaknesses
9.11 NutraPak USA
9.11.1 NutraPak USA Details
9.11.2 NutraPak USA Major Business
9.11.3 NutraPak USA Supplement CDMO Product and Services
9.11.4 NutraPak USA Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 NutraPak USA Recent Developments/Updates
9.11.6 NutraPak USA Competitive Strengths & Weaknesses
9.12 American Health Formulations
9.12.1 American Health Formulations Details
9.12.2 American Health Formulations Major Business
9.12.3 American Health Formulations Supplement CDMO Product and Services
9.12.4 American Health Formulations Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 American Health Formulations Recent Developments/Updates
9.12.6 American Health Formulations Competitive Strengths & Weaknesses
9.13 Aenova Group
9.13.1 Aenova Group Details
9.13.2 Aenova Group Major Business
9.13.3 Aenova Group Supplement CDMO Product and Services
9.13.4 Aenova Group Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Aenova Group Recent Developments/Updates
9.13.6 Aenova Group Competitive Strengths & Weaknesses
9.14 Robinson Pharma
9.14.1 Robinson Pharma Details
9.14.2 Robinson Pharma Major Business
9.14.3 Robinson Pharma Supplement CDMO Product and Services
9.14.4 Robinson Pharma Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Robinson Pharma Recent Developments/Updates
9.14.6 Robinson Pharma Competitive Strengths & Weaknesses
9.15 CAPTEK Softgel International
9.15.1 CAPTEK Softgel International Details
9.15.2 CAPTEK Softgel International Major Business
9.15.3 CAPTEK Softgel International Supplement CDMO Product and Services
9.15.4 CAPTEK Softgel International Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 CAPTEK Softgel International Recent Developments/Updates
9.15.6 CAPTEK Softgel International Competitive Strengths & Weaknesses
9.16 Makers Nutrition
9.16.1 Makers Nutrition Details
9.16.2 Makers Nutrition Major Business
9.16.3 Makers Nutrition Supplement CDMO Product and Services
9.16.4 Makers Nutrition Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Makers Nutrition Recent Developments/Updates
9.16.6 Makers Nutrition Competitive Strengths & Weaknesses
9.17 Goerlich Pharma
9.17.1 Goerlich Pharma Details
9.17.2 Goerlich Pharma Major Business
9.17.3 Goerlich Pharma Supplement CDMO Product and Services
9.17.4 Goerlich Pharma Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Goerlich Pharma Recent Developments/Updates
9.17.6 Goerlich Pharma Competitive Strengths & Weaknesses
9.18 API Co., Ltd
9.18.1 API Co., Ltd Details
9.18.2 API Co., Ltd Major Business
9.18.3 API Co., Ltd Supplement CDMO Product and Services
9.18.4 API Co., Ltd Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 API Co., Ltd Recent Developments/Updates
9.18.6 API Co., Ltd Competitive Strengths & Weaknesses
9.19 Kolmar BNH
9.19.1 Kolmar BNH Details
9.19.2 Kolmar BNH Major Business
9.19.3 Kolmar BNH Supplement CDMO Product and Services
9.19.4 Kolmar BNH Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Kolmar BNH Recent Developments/Updates
9.19.6 Kolmar BNH Competitive Strengths & Weaknesses
9.20 COSMAX BIO
9.20.1 COSMAX BIO Details
9.20.2 COSMAX BIO Major Business
9.20.3 COSMAX BIO Supplement CDMO Product and Services
9.20.4 COSMAX BIO Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 COSMAX BIO Recent Developments/Updates
9.20.6 COSMAX BIO Competitive Strengths & Weaknesses
9.21 NOVAREX
9.21.1 NOVAREX Details
9.21.2 NOVAREX Major Business
9.21.3 NOVAREX Supplement CDMO Product and Services
9.21.4 NOVAREX Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 NOVAREX Recent Developments/Updates
9.21.6 NOVAREX Competitive Strengths & Weaknesses
9.22 ORi Bionature
9.22.1 ORi Bionature Details
9.22.2 ORi Bionature Major Business
9.22.3 ORi Bionature Supplement CDMO Product and Services
9.22.4 ORi Bionature Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 ORi Bionature Recent Developments/Updates
9.22.6 ORi Bionature Competitive Strengths & Weaknesses
9.23 Sirio Pharma
9.23.1 Sirio Pharma Details
9.23.2 Sirio Pharma Major Business
9.23.3 Sirio Pharma Supplement CDMO Product and Services
9.23.4 Sirio Pharma Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Sirio Pharma Recent Developments/Updates
9.23.6 Sirio Pharma Competitive Strengths & Weaknesses
9.24 Baihe Biotech
9.24.1 Baihe Biotech Details
9.24.2 Baihe Biotech Major Business
9.24.3 Baihe Biotech Supplement CDMO Product and Services
9.24.4 Baihe Biotech Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Baihe Biotech Recent Developments/Updates
9.24.6 Baihe Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Supplement CDMO Industry Chain
10.2 Supplement CDMO Upstream Analysis
10.3 Supplement CDMO Midstream Analysis
10.4 Supplement CDMO Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Supplement CDMO Introduction
1.2 World Supplement CDMO Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Supplement CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Supplement CDMO Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Supplement CDMO Revenue (2021-2032)
1.3.3 China Based Company Supplement CDMO Revenue (2021-2032)
1.3.4 Europe Based Company Supplement CDMO Revenue (2021-2032)
1.3.5 Japan Based Company Supplement CDMO Revenue (2021-2032)
1.3.6 South Korea Based Company Supplement CDMO Revenue (2021-2032)
1.3.7 ASEAN Based Company Supplement CDMO Revenue (2021-2032)
1.3.8 India Based Company Supplement CDMO Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Supplement CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Supplement CDMO Consumption Value (2021-2032)
2.2 World Supplement CDMO Consumption Value by Region
2.2.1 World Supplement CDMO Consumption Value by Region (2021-2026)
2.2.2 World Supplement CDMO Consumption Value Forecast by Region (2027-2032)
2.3 United States Supplement CDMO Consumption Value (2021-2032)
2.4 China Supplement CDMO Consumption Value (2021-2032)
2.5 Europe Supplement CDMO Consumption Value (2021-2032)
2.6 Japan Supplement CDMO Consumption Value (2021-2032)
2.7 South Korea Supplement CDMO Consumption Value (2021-2032)
2.8 ASEAN Supplement CDMO Consumption Value (2021-2032)
2.9 India Supplement CDMO Consumption Value (2021-2032)
3 WORLD SUPPLEMENT CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Supplement CDMO Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Supplement CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Supplement CDMO in 2025
3.2.3 Global Concentration Ratios (CR8) for Supplement CDMO in 2025
3.3 Supplement CDMO Company Evaluation Quadrant
3.4 Supplement CDMO Market: Overall Company Footprint Analysis
3.4.1 Supplement CDMO Market: Region Footprint
3.4.2 Supplement CDMO Market: Company Product Type Footprint
3.4.3 Supplement CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Supplement CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Supplement CDMO Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Supplement CDMO Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Supplement CDMO Consumption Value Comparison
4.2.1 United States VS China: Supplement CDMO Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Supplement CDMO Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Supplement CDMO Companies and Market Share, 2021-2026
4.3.1 United States Based Supplement CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Supplement CDMO Revenue, (2021-2026)
4.4 China Based Companies Supplement CDMO Revenue and Market Share, 2021-2026
4.4.1 China Based Supplement CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Supplement CDMO Revenue, (2021-2026)
4.5 Rest of World Based Supplement CDMO Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Supplement CDMO Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Supplement CDMO Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Supplement CDMO Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 ?Small Molecule CDMO?
5.2.2 ?Large Molecule CDMO?
5.3 Market Segment by Type
5.3.1 World Supplement CDMO Market Size by Type (2021-2026)
5.3.2 World Supplement CDMO Market Size by Type (2027-2032)
5.3.3 World Supplement CDMO Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PRODUCT DOSAGE FORMS
6.1 World Supplement CDMO Market Size Overview by Product Dosage Forms: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Product Dosage Forms
6.2.1 Capsule Supplement CDMO
6.2.2 Tablet Supplement CDMO
6.2.3 Powder Supplement CDMO
6.2.4 Liquid Supplement CDMO
6.2.5 Others
6.3 Market Segment by Product Dosage Forms
6.3.1 World Supplement CDMO Market Size by Product Dosage Forms (2021-2026)
6.3.2 World Supplement CDMO Market Size by Product Dosage Forms (2027-2032)
6.3.3 World Supplement CDMO Market Size Market Share by Product Dosage Forms (2027-2032)
7 MARKET ANALYSIS BY PRODUCTION MODELS
7.1 World Supplement CDMO Market Size Overview by Production Models: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Models
7.2.1 Custom Formulation
7.2.2 Ready-made Formulation
7.2.3 Custom + Ready-made Formulation
7.3 Market Segment by Production Models
7.3.1 World Supplement CDMO Market Size by Production Models (2021-2026)
7.3.2 World Supplement CDMO Market Size by Production Models (2027-2032)
7.3.3 World Supplement CDMO Market Size Market Share by Production Models (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Supplement CDMO Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Sports Nutrition (Protein Powder, Amino Acids, Creatine, Electrolytes, etc.)
8.2.2 Digestive Health (Probiotics, Prebiotics, Digestive Enzymes, Dietary Fiber, etc.)
8.2.3 Immune Health (Vitamin C, Zinc, Elderberry, Immune Support Blends, etc.)
8.2.4 Bone & Joint Health (Calcium, Glucosamine, Chondroitin, Collagen, etc.)
8.2.5 Cardiovascular Health (Fish Oil, Omega-3, CoQ10, Plant Sterols, etc.)
8.2.6 Beauty & Wellness (Collagen, Biotin, Beauty Gummies, etc.)
8.2.7 Sleep & Mood Health (Melatonin, Magnesium, Theanine, etc.)
8.2.8 Others
8.3 Market Segment by Application
8.3.1 World Supplement CDMO Market Size by Application (2021-2026)
8.3.2 World Supplement CDMO Market Size by Application (2027-2032)
8.3.3 World Supplement CDMO Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Biofarma Group
9.1.1 Biofarma Group Details
9.1.2 Biofarma Group Major Business
9.1.3 Biofarma Group Supplement CDMO Product and Services
9.1.4 Biofarma Group Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Biofarma Group Recent Developments/Updates
9.1.6 Biofarma Group Competitive Strengths & Weaknesses
9.2 SFI Health Solutions
9.2.1 SFI Health Solutions Details
9.2.2 SFI Health Solutions Major Business
9.2.3 SFI Health Solutions Supplement CDMO Product and Services
9.2.4 SFI Health Solutions Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 SFI Health Solutions Recent Developments/Updates
9.2.6 SFI Health Solutions Competitive Strengths & Weaknesses
9.3 TCI Bio
9.3.1 TCI Bio Details
9.3.2 TCI Bio Major Business
9.3.3 TCI Bio Supplement CDMO Product and Services
9.3.4 TCI Bio Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 TCI Bio Recent Developments/Updates
9.3.6 TCI Bio Competitive Strengths & Weaknesses
9.4 Lonza
9.4.1 Lonza Details
9.4.2 Lonza Major Business
9.4.3 Lonza Supplement CDMO Product and Services
9.4.4 Lonza Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Lonza Recent Developments/Updates
9.4.6 Lonza Competitive Strengths & Weaknesses
9.5 HERMES PHARMA
9.5.1 HERMES PHARMA Details
9.5.2 HERMES PHARMA Major Business
9.5.3 HERMES PHARMA Supplement CDMO Product and Services
9.5.4 HERMES PHARMA Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 HERMES PHARMA Recent Developments/Updates
9.5.6 HERMES PHARMA Competitive Strengths & Weaknesses
9.6 Vitaquest
9.6.1 Vitaquest Details
9.6.2 Vitaquest Major Business
9.6.3 Vitaquest Supplement CDMO Product and Services
9.6.4 Vitaquest Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Vitaquest Recent Developments/Updates
9.6.6 Vitaquest Competitive Strengths & Weaknesses
9.7 Catalent
9.7.1 Catalent Details
9.7.2 Catalent Major Business
9.7.3 Catalent Supplement CDMO Product and Services
9.7.4 Catalent Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Catalent Recent Developments/Updates
9.7.6 Catalent Competitive Strengths & Weaknesses
9.8 KD Pharma Group
9.8.1 KD Pharma Group Details
9.8.2 KD Pharma Group Major Business
9.8.3 KD Pharma Group Supplement CDMO Product and Services
9.8.4 KD Pharma Group Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 KD Pharma Group Recent Developments/Updates
9.8.6 KD Pharma Group Competitive Strengths & Weaknesses
9.9 Pharma Tech Industries
9.9.1 Pharma Tech Industries Details
9.9.2 Pharma Tech Industries Major Business
9.9.3 Pharma Tech Industries Supplement CDMO Product and Services
9.9.4 Pharma Tech Industries Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Pharma Tech Industries Recent Developments/Updates
9.9.6 Pharma Tech Industries Competitive Strengths & Weaknesses
9.10 Pierre Fabre
9.10.1 Pierre Fabre Details
9.10.2 Pierre Fabre Major Business
9.10.3 Pierre Fabre Supplement CDMO Product and Services
9.10.4 Pierre Fabre Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Pierre Fabre Recent Developments/Updates
9.10.6 Pierre Fabre Competitive Strengths & Weaknesses
9.11 NutraPak USA
9.11.1 NutraPak USA Details
9.11.2 NutraPak USA Major Business
9.11.3 NutraPak USA Supplement CDMO Product and Services
9.11.4 NutraPak USA Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 NutraPak USA Recent Developments/Updates
9.11.6 NutraPak USA Competitive Strengths & Weaknesses
9.12 American Health Formulations
9.12.1 American Health Formulations Details
9.12.2 American Health Formulations Major Business
9.12.3 American Health Formulations Supplement CDMO Product and Services
9.12.4 American Health Formulations Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 American Health Formulations Recent Developments/Updates
9.12.6 American Health Formulations Competitive Strengths & Weaknesses
9.13 Aenova Group
9.13.1 Aenova Group Details
9.13.2 Aenova Group Major Business
9.13.3 Aenova Group Supplement CDMO Product and Services
9.13.4 Aenova Group Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Aenova Group Recent Developments/Updates
9.13.6 Aenova Group Competitive Strengths & Weaknesses
9.14 Robinson Pharma
9.14.1 Robinson Pharma Details
9.14.2 Robinson Pharma Major Business
9.14.3 Robinson Pharma Supplement CDMO Product and Services
9.14.4 Robinson Pharma Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Robinson Pharma Recent Developments/Updates
9.14.6 Robinson Pharma Competitive Strengths & Weaknesses
9.15 CAPTEK Softgel International
9.15.1 CAPTEK Softgel International Details
9.15.2 CAPTEK Softgel International Major Business
9.15.3 CAPTEK Softgel International Supplement CDMO Product and Services
9.15.4 CAPTEK Softgel International Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 CAPTEK Softgel International Recent Developments/Updates
9.15.6 CAPTEK Softgel International Competitive Strengths & Weaknesses
9.16 Makers Nutrition
9.16.1 Makers Nutrition Details
9.16.2 Makers Nutrition Major Business
9.16.3 Makers Nutrition Supplement CDMO Product and Services
9.16.4 Makers Nutrition Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Makers Nutrition Recent Developments/Updates
9.16.6 Makers Nutrition Competitive Strengths & Weaknesses
9.17 Goerlich Pharma
9.17.1 Goerlich Pharma Details
9.17.2 Goerlich Pharma Major Business
9.17.3 Goerlich Pharma Supplement CDMO Product and Services
9.17.4 Goerlich Pharma Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Goerlich Pharma Recent Developments/Updates
9.17.6 Goerlich Pharma Competitive Strengths & Weaknesses
9.18 API Co., Ltd
9.18.1 API Co., Ltd Details
9.18.2 API Co., Ltd Major Business
9.18.3 API Co., Ltd Supplement CDMO Product and Services
9.18.4 API Co., Ltd Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 API Co., Ltd Recent Developments/Updates
9.18.6 API Co., Ltd Competitive Strengths & Weaknesses
9.19 Kolmar BNH
9.19.1 Kolmar BNH Details
9.19.2 Kolmar BNH Major Business
9.19.3 Kolmar BNH Supplement CDMO Product and Services
9.19.4 Kolmar BNH Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Kolmar BNH Recent Developments/Updates
9.19.6 Kolmar BNH Competitive Strengths & Weaknesses
9.20 COSMAX BIO
9.20.1 COSMAX BIO Details
9.20.2 COSMAX BIO Major Business
9.20.3 COSMAX BIO Supplement CDMO Product and Services
9.20.4 COSMAX BIO Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 COSMAX BIO Recent Developments/Updates
9.20.6 COSMAX BIO Competitive Strengths & Weaknesses
9.21 NOVAREX
9.21.1 NOVAREX Details
9.21.2 NOVAREX Major Business
9.21.3 NOVAREX Supplement CDMO Product and Services
9.21.4 NOVAREX Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 NOVAREX Recent Developments/Updates
9.21.6 NOVAREX Competitive Strengths & Weaknesses
9.22 ORi Bionature
9.22.1 ORi Bionature Details
9.22.2 ORi Bionature Major Business
9.22.3 ORi Bionature Supplement CDMO Product and Services
9.22.4 ORi Bionature Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 ORi Bionature Recent Developments/Updates
9.22.6 ORi Bionature Competitive Strengths & Weaknesses
9.23 Sirio Pharma
9.23.1 Sirio Pharma Details
9.23.2 Sirio Pharma Major Business
9.23.3 Sirio Pharma Supplement CDMO Product and Services
9.23.4 Sirio Pharma Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Sirio Pharma Recent Developments/Updates
9.23.6 Sirio Pharma Competitive Strengths & Weaknesses
9.24 Baihe Biotech
9.24.1 Baihe Biotech Details
9.24.2 Baihe Biotech Major Business
9.24.3 Baihe Biotech Supplement CDMO Product and Services
9.24.4 Baihe Biotech Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Baihe Biotech Recent Developments/Updates
9.24.6 Baihe Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Supplement CDMO Industry Chain
10.2 Supplement CDMO Upstream Analysis
10.3 Supplement CDMO Midstream Analysis
10.4 Supplement CDMO Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Supplement CDMO Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Supplement CDMO Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Supplement CDMO Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Supplement CDMO Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Supplement CDMO Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Supplement CDMO Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Supplement CDMO Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Supplement CDMO Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Supplement CDMO Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Supplement CDMO Players in 2025
Table 12. World Supplement CDMO Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Supplement CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Supplement CDMO Players
Table 15. Supplement CDMO Market: Company Product Type Footprint
Table 16. Supplement CDMO Market: Company Product Application Footprint
Table 17. Supplement CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Supplement CDMO Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Supplement CDMO Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Supplement CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Supplement CDMO Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Supplement CDMO Revenue Market Share (2021-2026)
Table 23. China Based Supplement CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Supplement CDMO Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Supplement CDMO Revenue Market Share (2021-2026)
Table 26. Rest of World Based Supplement CDMO Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Supplement CDMO Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Supplement CDMO Revenue Market Share (2021-2026)
Table 29. World Supplement CDMO Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Supplement CDMO Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Supplement CDMO Market Size by Type (2027-2032) & (USD Million)
Table 32. World Supplement CDMO Market Size by Product Dosage Forms, (USD Million), 2021 & 2025 & 2032
Table 33. World Supplement CDMO Market Size Value by Product Dosage Forms (2021-2026) & (USD Million)
Table 34. World Supplement CDMO Market Size by Product Dosage Forms (2027-2032) & (USD Million)
Table 35. World Supplement CDMO Market Size by Production Models, (USD Million), 2021 & 2025 & 2032
Table 36. World Supplement CDMO Market Size Value by Production Models (2021-2026) & (USD Million)
Table 37. World Supplement CDMO Market Size by Production Models (2027-2032) & (USD Million)
Table 38. World Supplement CDMO Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Supplement CDMO Market Size by Application (2021-2026) & (USD Million)
Table 40. World Supplement CDMO Market Size by Application (2027-2032) & (USD Million)
Table 41. Biofarma Group Basic Information, Manufacturing Base and Competitors
Table 42. Biofarma Group Major Business
Table 43. Biofarma Group Supplement CDMO Product and Services
Table 44. Biofarma Group Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Biofarma Group Recent Developments/Updates
Table 46. Biofarma Group Competitive Strengths & Weaknesses
Table 47. SFI Health Solutions Basic Information, Manufacturing Base and Competitors
Table 48. SFI Health Solutions Major Business
Table 49. SFI Health Solutions Supplement CDMO Product and Services
Table 50. SFI Health Solutions Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. SFI Health Solutions Recent Developments/Updates
Table 52. SFI Health Solutions Competitive Strengths & Weaknesses
Table 53. TCI Bio Basic Information, Manufacturing Base and Competitors
Table 54. TCI Bio Major Business
Table 55. TCI Bio Supplement CDMO Product and Services
Table 56. TCI Bio Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. TCI Bio Recent Developments/Updates
Table 58. TCI Bio Competitive Strengths & Weaknesses
Table 59. Lonza Basic Information, Manufacturing Base and Competitors
Table 60. Lonza Major Business
Table 61. Lonza Supplement CDMO Product and Services
Table 62. Lonza Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Lonza Recent Developments/Updates
Table 64. Lonza Competitive Strengths & Weaknesses
Table 65. HERMES PHARMA Basic Information, Manufacturing Base and Competitors
Table 66. HERMES PHARMA Major Business
Table 67. HERMES PHARMA Supplement CDMO Product and Services
Table 68. HERMES PHARMA Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. HERMES PHARMA Recent Developments/Updates
Table 70. HERMES PHARMA Competitive Strengths & Weaknesses
Table 71. Vitaquest Basic Information, Manufacturing Base and Competitors
Table 72. Vitaquest Major Business
Table 73. Vitaquest Supplement CDMO Product and Services
Table 74. Vitaquest Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Vitaquest Recent Developments/Updates
Table 76. Vitaquest Competitive Strengths & Weaknesses
Table 77. Catalent Basic Information, Manufacturing Base and Competitors
Table 78. Catalent Major Business
Table 79. Catalent Supplement CDMO Product and Services
Table 80. Catalent Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Catalent Recent Developments/Updates
Table 82. Catalent Competitive Strengths & Weaknesses
Table 83. KD Pharma Group Basic Information, Manufacturing Base and Competitors
Table 84. KD Pharma Group Major Business
Table 85. KD Pharma Group Supplement CDMO Product and Services
Table 86. KD Pharma Group Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. KD Pharma Group Recent Developments/Updates
Table 88. KD Pharma Group Competitive Strengths & Weaknesses
Table 89. Pharma Tech Industries Basic Information, Manufacturing Base and Competitors
Table 90. Pharma Tech Industries Major Business
Table 91. Pharma Tech Industries Supplement CDMO Product and Services
Table 92. Pharma Tech Industries Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Pharma Tech Industries Recent Developments/Updates
Table 94. Pharma Tech Industries Competitive Strengths & Weaknesses
Table 95. Pierre Fabre Basic Information, Manufacturing Base and Competitors
Table 96. Pierre Fabre Major Business
Table 97. Pierre Fabre Supplement CDMO Product and Services
Table 98. Pierre Fabre Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Pierre Fabre Recent Developments/Updates
Table 100. Pierre Fabre Competitive Strengths & Weaknesses
Table 101. NutraPak USA Basic Information, Manufacturing Base and Competitors
Table 102. NutraPak USA Major Business
Table 103. NutraPak USA Supplement CDMO Product and Services
Table 104. NutraPak USA Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. NutraPak USA Recent Developments/Updates
Table 106. NutraPak USA Competitive Strengths & Weaknesses
Table 107. American Health Formulations Basic Information, Manufacturing Base and Competitors
Table 108. American Health Formulations Major Business
Table 109. American Health Formulations Supplement CDMO Product and Services
Table 110. American Health Formulations Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. American Health Formulations Recent Developments/Updates
Table 112. American Health Formulations Competitive Strengths & Weaknesses
Table 113. Aenova Group Basic Information, Manufacturing Base and Competitors
Table 114. Aenova Group Major Business
Table 115. Aenova Group Supplement CDMO Product and Services
Table 116. Aenova Group Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Aenova Group Recent Developments/Updates
Table 118. Aenova Group Competitive Strengths & Weaknesses
Table 119. Robinson Pharma Basic Information, Manufacturing Base and Competitors
Table 120. Robinson Pharma Major Business
Table 121. Robinson Pharma Supplement CDMO Product and Services
Table 122. Robinson Pharma Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Robinson Pharma Recent Developments/Updates
Table 124. Robinson Pharma Competitive Strengths & Weaknesses
Table 125. CAPTEK Softgel International Basic Information, Manufacturing Base and Competitors
Table 126. CAPTEK Softgel International Major Business
Table 127. CAPTEK Softgel International Supplement CDMO Product and Services
Table 128. CAPTEK Softgel International Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. CAPTEK Softgel International Recent Developments/Updates
Table 130. CAPTEK Softgel International Competitive Strengths & Weaknesses
Table 131. Makers Nutrition Basic Information, Manufacturing Base and Competitors
Table 132. Makers Nutrition Major Business
Table 133. Makers Nutrition Supplement CDMO Product and Services
Table 134. Makers Nutrition Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Makers Nutrition Recent Developments/Updates
Table 136. Makers Nutrition Competitive Strengths & Weaknesses
Table 137. Goerlich Pharma Basic Information, Manufacturing Base and Competitors
Table 138. Goerlich Pharma Major Business
Table 139. Goerlich Pharma Supplement CDMO Product and Services
Table 140. Goerlich Pharma Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Goerlich Pharma Recent Developments/Updates
Table 142. Goerlich Pharma Competitive Strengths & Weaknesses
Table 143. API Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 144. API Co., Ltd Major Business
Table 145. API Co., Ltd Supplement CDMO Product and Services
Table 146. API Co., Ltd Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. API Co., Ltd Recent Developments/Updates
Table 148. API Co., Ltd Competitive Strengths & Weaknesses
Table 149. Kolmar BNH Basic Information, Manufacturing Base and Competitors
Table 150. Kolmar BNH Major Business
Table 151. Kolmar BNH Supplement CDMO Product and Services
Table 152. Kolmar BNH Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Kolmar BNH Recent Developments/Updates
Table 154. Kolmar BNH Competitive Strengths & Weaknesses
Table 155. COSMAX BIO Basic Information, Manufacturing Base and Competitors
Table 156. COSMAX BIO Major Business
Table 157. COSMAX BIO Supplement CDMO Product and Services
Table 158. COSMAX BIO Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. COSMAX BIO Recent Developments/Updates
Table 160. COSMAX BIO Competitive Strengths & Weaknesses
Table 161. NOVAREX Basic Information, Manufacturing Base and Competitors
Table 162. NOVAREX Major Business
Table 163. NOVAREX Supplement CDMO Product and Services
Table 164. NOVAREX Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. NOVAREX Recent Developments/Updates
Table 166. NOVAREX Competitive Strengths & Weaknesses
Table 167. ORi Bionature Basic Information, Manufacturing Base and Competitors
Table 168. ORi Bionature Major Business
Table 169. ORi Bionature Supplement CDMO Product and Services
Table 170. ORi Bionature Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. ORi Bionature Recent Developments/Updates
Table 172. ORi Bionature Competitive Strengths & Weaknesses
Table 173. Sirio Pharma Basic Information, Manufacturing Base and Competitors
Table 174. Sirio Pharma Major Business
Table 175. Sirio Pharma Supplement CDMO Product and Services
Table 176. Sirio Pharma Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Sirio Pharma Recent Developments/Updates
Table 178. Sirio Pharma Competitive Strengths & Weaknesses
Table 179. Baihe Biotech Basic Information, Manufacturing Base and Competitors
Table 180. Baihe Biotech Major Business
Table 181. Baihe Biotech Supplement CDMO Product and Services
Table 182. Baihe Biotech Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Baihe Biotech Recent Developments/Updates
Table 184. Baihe Biotech Competitive Strengths & Weaknesses
Table 185. Global Key Players of Supplement CDMO Upstream (Raw Materials)
Table 186. Global Supplement CDMO Typical Customers
Table 1. World Supplement CDMO Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Supplement CDMO Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Supplement CDMO Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Supplement CDMO Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Supplement CDMO Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Supplement CDMO Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Supplement CDMO Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Supplement CDMO Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Supplement CDMO Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Supplement CDMO Players in 2025
Table 12. World Supplement CDMO Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Supplement CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Supplement CDMO Players
Table 15. Supplement CDMO Market: Company Product Type Footprint
Table 16. Supplement CDMO Market: Company Product Application Footprint
Table 17. Supplement CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Supplement CDMO Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Supplement CDMO Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Supplement CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Supplement CDMO Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Supplement CDMO Revenue Market Share (2021-2026)
Table 23. China Based Supplement CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Supplement CDMO Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Supplement CDMO Revenue Market Share (2021-2026)
Table 26. Rest of World Based Supplement CDMO Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Supplement CDMO Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Supplement CDMO Revenue Market Share (2021-2026)
Table 29. World Supplement CDMO Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Supplement CDMO Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Supplement CDMO Market Size by Type (2027-2032) & (USD Million)
Table 32. World Supplement CDMO Market Size by Product Dosage Forms, (USD Million), 2021 & 2025 & 2032
Table 33. World Supplement CDMO Market Size Value by Product Dosage Forms (2021-2026) & (USD Million)
Table 34. World Supplement CDMO Market Size by Product Dosage Forms (2027-2032) & (USD Million)
Table 35. World Supplement CDMO Market Size by Production Models, (USD Million), 2021 & 2025 & 2032
Table 36. World Supplement CDMO Market Size Value by Production Models (2021-2026) & (USD Million)
Table 37. World Supplement CDMO Market Size by Production Models (2027-2032) & (USD Million)
Table 38. World Supplement CDMO Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Supplement CDMO Market Size by Application (2021-2026) & (USD Million)
Table 40. World Supplement CDMO Market Size by Application (2027-2032) & (USD Million)
Table 41. Biofarma Group Basic Information, Manufacturing Base and Competitors
Table 42. Biofarma Group Major Business
Table 43. Biofarma Group Supplement CDMO Product and Services
Table 44. Biofarma Group Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Biofarma Group Recent Developments/Updates
Table 46. Biofarma Group Competitive Strengths & Weaknesses
Table 47. SFI Health Solutions Basic Information, Manufacturing Base and Competitors
Table 48. SFI Health Solutions Major Business
Table 49. SFI Health Solutions Supplement CDMO Product and Services
Table 50. SFI Health Solutions Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. SFI Health Solutions Recent Developments/Updates
Table 52. SFI Health Solutions Competitive Strengths & Weaknesses
Table 53. TCI Bio Basic Information, Manufacturing Base and Competitors
Table 54. TCI Bio Major Business
Table 55. TCI Bio Supplement CDMO Product and Services
Table 56. TCI Bio Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. TCI Bio Recent Developments/Updates
Table 58. TCI Bio Competitive Strengths & Weaknesses
Table 59. Lonza Basic Information, Manufacturing Base and Competitors
Table 60. Lonza Major Business
Table 61. Lonza Supplement CDMO Product and Services
Table 62. Lonza Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Lonza Recent Developments/Updates
Table 64. Lonza Competitive Strengths & Weaknesses
Table 65. HERMES PHARMA Basic Information, Manufacturing Base and Competitors
Table 66. HERMES PHARMA Major Business
Table 67. HERMES PHARMA Supplement CDMO Product and Services
Table 68. HERMES PHARMA Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. HERMES PHARMA Recent Developments/Updates
Table 70. HERMES PHARMA Competitive Strengths & Weaknesses
Table 71. Vitaquest Basic Information, Manufacturing Base and Competitors
Table 72. Vitaquest Major Business
Table 73. Vitaquest Supplement CDMO Product and Services
Table 74. Vitaquest Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Vitaquest Recent Developments/Updates
Table 76. Vitaquest Competitive Strengths & Weaknesses
Table 77. Catalent Basic Information, Manufacturing Base and Competitors
Table 78. Catalent Major Business
Table 79. Catalent Supplement CDMO Product and Services
Table 80. Catalent Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Catalent Recent Developments/Updates
Table 82. Catalent Competitive Strengths & Weaknesses
Table 83. KD Pharma Group Basic Information, Manufacturing Base and Competitors
Table 84. KD Pharma Group Major Business
Table 85. KD Pharma Group Supplement CDMO Product and Services
Table 86. KD Pharma Group Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. KD Pharma Group Recent Developments/Updates
Table 88. KD Pharma Group Competitive Strengths & Weaknesses
Table 89. Pharma Tech Industries Basic Information, Manufacturing Base and Competitors
Table 90. Pharma Tech Industries Major Business
Table 91. Pharma Tech Industries Supplement CDMO Product and Services
Table 92. Pharma Tech Industries Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Pharma Tech Industries Recent Developments/Updates
Table 94. Pharma Tech Industries Competitive Strengths & Weaknesses
Table 95. Pierre Fabre Basic Information, Manufacturing Base and Competitors
Table 96. Pierre Fabre Major Business
Table 97. Pierre Fabre Supplement CDMO Product and Services
Table 98. Pierre Fabre Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Pierre Fabre Recent Developments/Updates
Table 100. Pierre Fabre Competitive Strengths & Weaknesses
Table 101. NutraPak USA Basic Information, Manufacturing Base and Competitors
Table 102. NutraPak USA Major Business
Table 103. NutraPak USA Supplement CDMO Product and Services
Table 104. NutraPak USA Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. NutraPak USA Recent Developments/Updates
Table 106. NutraPak USA Competitive Strengths & Weaknesses
Table 107. American Health Formulations Basic Information, Manufacturing Base and Competitors
Table 108. American Health Formulations Major Business
Table 109. American Health Formulations Supplement CDMO Product and Services
Table 110. American Health Formulations Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. American Health Formulations Recent Developments/Updates
Table 112. American Health Formulations Competitive Strengths & Weaknesses
Table 113. Aenova Group Basic Information, Manufacturing Base and Competitors
Table 114. Aenova Group Major Business
Table 115. Aenova Group Supplement CDMO Product and Services
Table 116. Aenova Group Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Aenova Group Recent Developments/Updates
Table 118. Aenova Group Competitive Strengths & Weaknesses
Table 119. Robinson Pharma Basic Information, Manufacturing Base and Competitors
Table 120. Robinson Pharma Major Business
Table 121. Robinson Pharma Supplement CDMO Product and Services
Table 122. Robinson Pharma Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Robinson Pharma Recent Developments/Updates
Table 124. Robinson Pharma Competitive Strengths & Weaknesses
Table 125. CAPTEK Softgel International Basic Information, Manufacturing Base and Competitors
Table 126. CAPTEK Softgel International Major Business
Table 127. CAPTEK Softgel International Supplement CDMO Product and Services
Table 128. CAPTEK Softgel International Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. CAPTEK Softgel International Recent Developments/Updates
Table 130. CAPTEK Softgel International Competitive Strengths & Weaknesses
Table 131. Makers Nutrition Basic Information, Manufacturing Base and Competitors
Table 132. Makers Nutrition Major Business
Table 133. Makers Nutrition Supplement CDMO Product and Services
Table 134. Makers Nutrition Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Makers Nutrition Recent Developments/Updates
Table 136. Makers Nutrition Competitive Strengths & Weaknesses
Table 137. Goerlich Pharma Basic Information, Manufacturing Base and Competitors
Table 138. Goerlich Pharma Major Business
Table 139. Goerlich Pharma Supplement CDMO Product and Services
Table 140. Goerlich Pharma Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Goerlich Pharma Recent Developments/Updates
Table 142. Goerlich Pharma Competitive Strengths & Weaknesses
Table 143. API Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 144. API Co., Ltd Major Business
Table 145. API Co., Ltd Supplement CDMO Product and Services
Table 146. API Co., Ltd Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. API Co., Ltd Recent Developments/Updates
Table 148. API Co., Ltd Competitive Strengths & Weaknesses
Table 149. Kolmar BNH Basic Information, Manufacturing Base and Competitors
Table 150. Kolmar BNH Major Business
Table 151. Kolmar BNH Supplement CDMO Product and Services
Table 152. Kolmar BNH Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Kolmar BNH Recent Developments/Updates
Table 154. Kolmar BNH Competitive Strengths & Weaknesses
Table 155. COSMAX BIO Basic Information, Manufacturing Base and Competitors
Table 156. COSMAX BIO Major Business
Table 157. COSMAX BIO Supplement CDMO Product and Services
Table 158. COSMAX BIO Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. COSMAX BIO Recent Developments/Updates
Table 160. COSMAX BIO Competitive Strengths & Weaknesses
Table 161. NOVAREX Basic Information, Manufacturing Base and Competitors
Table 162. NOVAREX Major Business
Table 163. NOVAREX Supplement CDMO Product and Services
Table 164. NOVAREX Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. NOVAREX Recent Developments/Updates
Table 166. NOVAREX Competitive Strengths & Weaknesses
Table 167. ORi Bionature Basic Information, Manufacturing Base and Competitors
Table 168. ORi Bionature Major Business
Table 169. ORi Bionature Supplement CDMO Product and Services
Table 170. ORi Bionature Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. ORi Bionature Recent Developments/Updates
Table 172. ORi Bionature Competitive Strengths & Weaknesses
Table 173. Sirio Pharma Basic Information, Manufacturing Base and Competitors
Table 174. Sirio Pharma Major Business
Table 175. Sirio Pharma Supplement CDMO Product and Services
Table 176. Sirio Pharma Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Sirio Pharma Recent Developments/Updates
Table 178. Sirio Pharma Competitive Strengths & Weaknesses
Table 179. Baihe Biotech Basic Information, Manufacturing Base and Competitors
Table 180. Baihe Biotech Major Business
Table 181. Baihe Biotech Supplement CDMO Product and Services
Table 182. Baihe Biotech Supplement CDMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Baihe Biotech Recent Developments/Updates
Table 184. Baihe Biotech Competitive Strengths & Weaknesses
Table 185. Global Key Players of Supplement CDMO Upstream (Raw Materials)
Table 186. Global Supplement CDMO Typical Customers
LIST OF FIGURES
Figure 1. Supplement CDMO Picture
Figure 2. World Supplement CDMO Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Supplement CDMO Total Revenue (2021-2032) & (USD Million)
Figure 4. World Supplement CDMO Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Supplement CDMO Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Supplement CDMO Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Supplement CDMO Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Supplement CDMO Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Supplement CDMO Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Supplement CDMO Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Supplement CDMO Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Supplement CDMO Revenue (2021-2032) & (USD Million)
Figure 13. Supplement CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 16. World Supplement CDMO Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 18. China Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 23. India Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Supplement CDMO by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Supplement CDMO Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Supplement CDMO Markets in 2025
Figure 27. United States VS China: Supplement CDMO Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Supplement CDMO Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Supplement CDMO Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Supplement CDMO Market Size Market Share by Type in 2025
Figure 31. ?Small Molecule CDMO?
Figure 32. ?Large Molecule CDMO?
Figure 33. World Supplement CDMO Market Size Market Share by Type (2021-2032)
Figure 34. World Supplement CDMO Market Size by Product Dosage Forms, (USD Million), 2021 & 2025 & 2032
Figure 35. World Supplement CDMO Market Size Market Share by Product Dosage Forms in 2025
Figure 36. Capsule Supplement CDMO
Figure 37. Tablet Supplement CDMO
Figure 38. Powder Supplement CDMO
Figure 39. Liquid Supplement CDMO
Figure 40. Others
Figure 41. World Supplement CDMO Market Size Market Share by Product Dosage Forms (2021-2032)
Figure 42. World Supplement CDMO Market Size by Production Models, (USD Million), 2021 & 2025 & 2032
Figure 43. World Supplement CDMO Market Size Market Share by Production Models in 2025
Figure 44. Custom Formulation
Figure 45. Ready-made Formulation
Figure 46. Custom + Ready-made Formulation
Figure 47. World Supplement CDMO Market Size Market Share by Production Models (2021-2032)
Figure 48. World Supplement CDMO Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Supplement CDMO Market Size Market Share by Application in 2025
Figure 50. Sports Nutrition (Protein Powder, Amino Acids, Creatine, Electrolytes, etc.)
Figure 51. Digestive Health (Probiotics, Prebiotics, Digestive Enzymes, Dietary Fiber, etc.)
Figure 52. Immune Health (Vitamin C, Zinc, Elderberry, Immune Support Blends, etc.)
Figure 53. Bone & Joint Health (Calcium, Glucosamine, Chondroitin, Collagen, etc.)
Figure 54. Cardiovascular Health (Fish Oil, Omega-3, CoQ10, Plant Sterols, etc.)
Figure 55. Beauty & Wellness (Collagen, Biotin, Beauty Gummies, etc.)
Figure 56. Sleep & Mood Health (Melatonin, Magnesium, Theanine, etc.)
Figure 57. Others
Figure 58. Others
Figure 59. World Supplement CDMO Market Size Market Share by Application (2021-2032)
Figure 60. Supplement CDMO Industrial Chain
Figure 61. Methodology
Figure 62. Research Process and Data Source
Figure 1. Supplement CDMO Picture
Figure 2. World Supplement CDMO Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Supplement CDMO Total Revenue (2021-2032) & (USD Million)
Figure 4. World Supplement CDMO Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Supplement CDMO Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Supplement CDMO Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Supplement CDMO Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Supplement CDMO Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Supplement CDMO Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Supplement CDMO Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Supplement CDMO Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Supplement CDMO Revenue (2021-2032) & (USD Million)
Figure 13. Supplement CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 16. World Supplement CDMO Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 18. China Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 23. India Supplement CDMO Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Supplement CDMO by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Supplement CDMO Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Supplement CDMO Markets in 2025
Figure 27. United States VS China: Supplement CDMO Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Supplement CDMO Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Supplement CDMO Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Supplement CDMO Market Size Market Share by Type in 2025
Figure 31. ?Small Molecule CDMO?
Figure 32. ?Large Molecule CDMO?
Figure 33. World Supplement CDMO Market Size Market Share by Type (2021-2032)
Figure 34. World Supplement CDMO Market Size by Product Dosage Forms, (USD Million), 2021 & 2025 & 2032
Figure 35. World Supplement CDMO Market Size Market Share by Product Dosage Forms in 2025
Figure 36. Capsule Supplement CDMO
Figure 37. Tablet Supplement CDMO
Figure 38. Powder Supplement CDMO
Figure 39. Liquid Supplement CDMO
Figure 40. Others
Figure 41. World Supplement CDMO Market Size Market Share by Product Dosage Forms (2021-2032)
Figure 42. World Supplement CDMO Market Size by Production Models, (USD Million), 2021 & 2025 & 2032
Figure 43. World Supplement CDMO Market Size Market Share by Production Models in 2025
Figure 44. Custom Formulation
Figure 45. Ready-made Formulation
Figure 46. Custom + Ready-made Formulation
Figure 47. World Supplement CDMO Market Size Market Share by Production Models (2021-2032)
Figure 48. World Supplement CDMO Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Supplement CDMO Market Size Market Share by Application in 2025
Figure 50. Sports Nutrition (Protein Powder, Amino Acids, Creatine, Electrolytes, etc.)
Figure 51. Digestive Health (Probiotics, Prebiotics, Digestive Enzymes, Dietary Fiber, etc.)
Figure 52. Immune Health (Vitamin C, Zinc, Elderberry, Immune Support Blends, etc.)
Figure 53. Bone & Joint Health (Calcium, Glucosamine, Chondroitin, Collagen, etc.)
Figure 54. Cardiovascular Health (Fish Oil, Omega-3, CoQ10, Plant Sterols, etc.)
Figure 55. Beauty & Wellness (Collagen, Biotin, Beauty Gummies, etc.)
Figure 56. Sleep & Mood Health (Melatonin, Magnesium, Theanine, etc.)
Figure 57. Others
Figure 58. Others
Figure 59. World Supplement CDMO Market Size Market Share by Application (2021-2032)
Figure 60. Supplement CDMO Industrial Chain
Figure 61. Methodology
Figure 62. Research Process and Data Source
